Empagliflozin (SGLT2 Inhibitor)
Treatment used for 1 condition
Total Trials
69
Total Participants
80K
Avg Effectiveness
89%
Avg Safety Score
60%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.
Treatment used for 1 condition
Click on a condition to view detailed treatment information and clinical trial data.